NEWS

LIFEX update

We are announcing phase one LIFEX token offering has ended.

LIFEX project is now able to proceed with its project with support from angel investors and pre-sales.

Due to the synergy of related members, LIFEX is capable of covering large area. Also, to successfully build new generation medical platform which does not exist yet in the blockchain field, LIFEX were expecting to set the lead time longer. Considering the circumstances of crypto field and since it is difficult to construct the whole concept of which LIFEX plans, decision of closing the procurement as phase one were made, believing that making progress for realizing projects is the most important factor.

Therefore, LIFEX is announcing and has begun constructing its own blockchain network.

Development will be operated by a team with the core council, Nakamura, CEO of OKEIOS Inc., subsidiary company of OKWAVE. OKEISO’s lifelog information circulation platform, combination of blockchain and decentralized secret storage technology, has high reputation in Japan. Utilizing its knowledge and the brains of various councilors, LIFEX will construct most efficient LIFEX Blockchain Network for handling medical data with authenticity, maintainability and utilization.

The data acquired from blockchain and its analysis results can be used not only for development of specific medicines and preventive medicine by discovering common points such as diseases in the large universe, but also for regenerative medicine and personalized medicine.

LIFEX will bring solutions for the issues occurred from longer lives, increase in medical expenses, negative effects and other problems within the medical industry by sharing big data, which is obtained from blockchain technology to the world, aiming to enhance the development of new medicine, improve and expansion medical industry.

To create better society from different point of view, we will support LIFEX to bring excitement from medical field. Thank you for the support.

Presale Closed!

The presale of Lifex token has now closed!

Thank you for your participation, and we will be updating the next token sale date through our website soon.

Presale and KYC registration is now open!

We are thrilled to announce that the presale and KYC registration for joining has now officially opened!

We ask anyone interested in our project to read our whitepaper very carefully, and only join our sale if qualified.

Thank you for your understanding.

New members in LIFEX and presale date determined

We are excited to announce that there will be new members joining our LIFEX project!

-Mr. Yoshitake Awa (CEO of LIFEX RESEARCH PTE. LTD.)
-Mr. Winston Patrick Eric Koike (Advisor of LIFEX Project)
The changes are to be made to expand the business model of LIFEX project with unique backgrounds in the finance industry of above members.

Also due to the changes, the schedule of LIFEX token sale is rescheduled, and the presale is currently scheduled to take place on July 28th, 2018. We will be updating more information of the sales soon.

Below are the profile of Mr. Awa and Mr. Koike:

Awa has a vast experience and knowledge in financial industry through his 30 years of career in Japan, US and Singapore. He has held various positions at major investment banks and asset managers, such as Nomura Securities, Barclays de Zouete Wedd, BNP Paribas and UOB Asset Management.

Winston Patrick Eric Koike is the Director of AP Investment Advisory Services Pte. Ltd. director of AP Advisory Services Ltd., Kenzo Capital and Kenzo GmbH. From many years of working experiences in Morgan Stanley, HSBC and other large finance group, he continuously have been serving for many partners across the world.

Mr. Awa comments as below:

“I believe that the combination of advance medicine and blockchain technology will be the significant characteristic of LIFEX project. I also think the partnership with I’ROM Group of Japan enables us to enhance the quality of our service because of its wide networks with medical institutions & pharmaceutical companies and achievements in advance medical treatment business. I hope my years of working experience and personal connection cultivated in finance industry can be utilized for the future prosperity of our firm.